Diagnostic yield of genetic testing in heart transplant recipients with prior cardiomyopathy

[1]  S. Heymans,et al.  Understanding the genetics of adult-onset dilated cardiomyopathy: what a clinician needs to know. , 2021, European heart journal.

[2]  K. Musunuru,et al.  Genetic Testing for Inherited Cardiovascular Diseases: A Scientific Statement From the American Heart Association. , 2020, Circulation. Genomic and precision medicine.

[3]  S. Heymans,et al.  A mutation update for the FLNC gene in myopathies and cardiomyopathies , 2020, Human mutation.

[4]  Shengshou Hu,et al.  Multiple genetic variants in adolescent patients with left ventricular noncompaction cardiomyopathy. , 2019, International journal of cardiology.

[5]  B. Meiser,et al.  The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: Thirty-sixth adult heart transplantation report - 2019; focus theme: Donor and recipient size match. , 2019, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[6]  J. Lopes,et al.  Genetic variants identified by target next-generation sequencing in heart transplant patients with dilated cardiomyopathy. , 2019, Revista portuguesa de cardiologia : orgao oficial da Sociedade Portuguesa de Cardiologia = Portuguese journal of cardiology : an official journal of the Portuguese Society of Cardiology.

[7]  Parth N. Patel,et al.  Genetic Variants Associated With Cancer Therapy–Induced Cardiomyopathy , 2019, Circulation.

[8]  D. Judge,et al.  Genetic evaluation of cardiomyopathy: a clinical practice resource of the American College of Medical Genetics and Genomics (ACMG) , 2018, Genetics in Medicine.

[9]  D. O’Regan,et al.  Genetic Etiology for Alcohol-Induced Cardiac Toxicity , 2018, Journal of the American College of Cardiology.

[10]  S. Cook,et al.  Role of titin in cardiomyopathy: from DNA variants to patient stratification , 2018, Nature Reviews Cardiology.

[11]  Karen S. Frese,et al.  Clinical genetics and outcome of left ventricular non-compaction cardiomyopathy , 2017, European heart journal.

[12]  G. Mortier,et al.  Targeted Next-Generation Sequencing of 51 Genes Involved in Primary Electrical Disease. , 2017, The Journal of molecular diagnostics : JMD.

[13]  P. Ponikowski,et al.  2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure , 2016, Revista espanola de cardiologia.

[14]  Volkmar Falk,et al.  2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure , 2016, Revista espanola de cardiologia.

[15]  L. Monserrat,et al.  Genetic basis of familial dilated cardiomyopathy patients undergoing heart transplantation. , 2016, The Journal of Heart and Lung Transplantation.

[16]  L. Sugeng,et al.  Familial dilated cardiomyopathy diagnosis is commonly overlooked at the time of transplant listing. , 2016, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[17]  J. Seidman,et al.  Shared Genetic Predisposition in Peripartum and Dilated Cardiomyopathies. , 2016, The New England journal of medicine.

[18]  R. Hershberger,et al.  Dilated Cardiomyopathy Overview , 2015 .

[19]  D. Roden,et al.  Performant Mutation Identification Using Targeted Next‐Generation Sequencing of 14 Thoracic Aortic Aneurysm Genes , 2015, Human mutation.

[20]  Bale,et al.  Standards and Guidelines for the Interpretation of Sequence Variants: A Joint Consensus Recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology , 2015, Genetics in Medicine.

[21]  K. Sliwa,et al.  Titin gene mutations are common in families with both peripartum cardiomyopathy and dilated cardiomyopathy. , 2014, European heart journal.

[22]  D. Hedges,et al.  Dilated cardiomyopathy: the complexity of a diverse genetic architecture , 2013, Nature Reviews Cardiology.

[23]  J. Atherton,et al.  Clinical predictors of genetic testing outcomes in hypertrophic cardiomyopathy , 2013, Genetics in Medicine.

[24]  L. Mestroni,et al.  Truncations of titin causing dilated cardiomyopathy. , 2012, The New England journal of medicine.

[25]  H. Calkins,et al.  HRS/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies this document was developed as a partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA). , 2011, Heart rhythm.

[26]  Michael J Ackerman,et al.  HRS/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies: this document was developed as a partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA). , 2011, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[27]  H. Watkins,et al.  DNA testing for hypertrophic cardiomyopathy: a cost-effectiveness model. , 2010, European heart journal.

[28]  Eloisa Arbustini,et al.  Classification of the cardiomyopathies: a position statement from the European Society Of Cardiology Working Group on Myocardial and Pericardial Diseases. , 2007, European heart journal.

[29]  Stuart Russell,et al.  Listing criteria for heart transplantation: International Society for Heart and Lung Transplantation guidelines for the care of cardiac transplant candidates--2006. , 2006, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[30]  A. Tajik,et al.  Yield of genetic testing in hypertrophic cardiomyopathy. , 2005, Mayo Clinic proceedings.

[31]  J. Svendsen,et al.  Heart transplantation in arrhythmogenic right ventricular cardiomyopathy - Experience from the Nordic ARVC Registry. , 2018, International journal of cardiology.

[32]  R. Hershberger,et al.  Genetic cardiomyopathies , 2018, Current opinion in cardiology.

[33]  Jeffrey M. Vinocur,et al.  Hereditary arrhythmias and cardiomyopathies: decision-making about genetic testing , 2018, Current opinion in cardiology.

[34]  Marilyn M. Li,et al.  Standards and Guidelines for the Interpretation and Reporting of Sequence Variants in Cancer: A Joint Consensus Recommendation of the Association for Molecular Pathology, American Society of Clinical Oncology, and College of American Pathologists. , 2017, The Journal of molecular diagnostics : JMD.

[35]  M. Hannan,et al.  The 2016 International Society for Heart Lung Transplantation listing criteria for heart transplantation: A 10-year update. , 2016, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[36]  Biykem Bozkurt,et al.  2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. , 2013, Circulation.

[37]  S. Jayalakshmi,et al.  Peripartum cardiomyopathy. , 1980, Journal of the Indian Medical Association.